Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Racial Disparities in COVID-19: Causes, Consequences, and Clinical Strategies—Audio Recap

Listen to insights from expert faculty on the health inequities that cause racial disparities in COVID-19 outcomes, as well as strategies to overcome barriers to optimal prevention, testing, and treatment of COVID-19 among persons who are Black, indigenous, or people of color.
person default
Oni Blackstock, MD
person default
Nina T. Harawa, PhD, MPH
Released: October 29, 2021

In this episode, Oni Blackstock, MD, MHS, and Nina T. Harawa, PhD, MPH, discuss racial disparities in COVID-19 outcomes, including:

  • Background on healthcare inequities among BIPOC
  • COVID-19 racial disparities and the healthcare inequities driving them
  • Overcoming barriers to optimal COVID-19 care among BIPOC
  • Addressing concerns about COVID-19 vaccination  
  • Motivational interviewing principles and the brief negotiated interview to earn trust and increase vaccine acceptance


Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.

Information on this Educational Activity


Oni Blackstock, MD

Founder & Executive Director
Health Justice
New York, New York

Oni Blackstock, MD, MHS, has no relevant conflicts of interest to report.
Nina T. Harawa, PhD, MPH

Professor of Medicine and Epidemiology
Department of Medicine and Psychiatry
UCLA David Geffen School of Medicine
Charles R. Drew University of Medicine and Science
Los Angeles, California

Nina T. Harawa, PhD, MPH, has disclosed that she has received funds for research support and fees for non-CME/CE services from Gilead Sciences.

Program Medium

This program has been made available online.

Related Content

Learn from Dr Jonathan Appelbaum about medical challenges faced by aging people with HIV, from Clinical Care Options (CCO)

Jonathan Appelbaum, MD, FACP, AAHIVS
Program Director
Released: August 17, 2022

Expert insights on HIV PrEP medications, guideline updates, and solutions to uptake barriers, from Dr Gregory Huhn and Clinical Care Options (CCO)

Gregory Huhn, MD, MPHTM Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 12, 2022 Expired: August 11, 2023

Clinical Care Options (CCO) commentary from Dr Darrell Tan on the dosing options for long-acting injectable cabotegravir plus rilpivirine for HIV treatment

Babafemi Taiwo, MBBS
Program Director
Darrell H. S. Tan, MD, FRCPC, PhD
Released: August 12, 2022

Clinical Care Options (CCO) expert Carolyn Chu, MD, MSc, discusses how to improve HIV pre-exposure prophylaxis accessibility and availability for PWID

person default Carolyn Chu, MD, MSc, FAAFP, AAHIVS Released: August 12, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings